M. K. Proteins (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
M. K. Proteins Limited |
|||
Price: ₹8.03 | |||
52 Week Low: ₹7.20 52 Week High: ₹28.67 |
|||
Market Capital: 292.4 Crore (Smallcap) | |||
Consumer Defensive -> Packaged Foods |
Show Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: M. K. Proteins Share Price Target For 2024
- 1.1.1: M. K. Proteins Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: M. K. Proteins Share Price Target For 2025
- 1.2.1: M. K. Proteins Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 3: M. K. Proteins Brief Company Overview
- 4: M. K. Proteins Financial Performance
- 4.0.1: Is M. K. Proteins A Good Buy For Long Term?
To predict the M. K. Proteins's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
M. K. Proteins Share Price Target For 2024
The line chart displays the monthly closing prices of M. K. Proteins with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for M. K. Proteins shares in 2024, see the table below.
M. K. Proteins Share Price Target Table For 2024
Level | Value | Analysis |
---|---|---|
2024 Target 3 | 8.46 (+5.35%) | Price Action: 10 Dec 2024 High |
2024 Target 2 | 8.34 (+3.86%) | Price Action: 17 Dec 2024 High |
2024 Target 1 | 8.25 (+2.73%) | Price Action: 23 Oct 2024 Low |
Current Price | 8.03 | M. K. Proteins's share price as of 20 Dec 2024 |
Stop Loss 1 | 7.9 (-1.62%) | Price Action: Oct 2024 Low |
Stop Loss 2 | 7.8 (-2.87%) | Price Action: 21 Nov 2024 High |
Stop Loss 3 | 7.65 (-4.74%) | Price Action: 25 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: M. K. Proteins is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹8.32 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.07% | 6-month: -32.86% | 1-year: -71.33%
M. K. Proteins Share Price Target For 2025
The line chart displays the monthly closing prices of M. K. Proteins with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for M. K. Proteins shares in 2025, see the table below.
M. K. Proteins Share Price Target Table For 2025
Level | Value | Analysis |
---|---|---|
2025 Target 3 | 24.59 (+206.22%) | Price Action: Chart |
2025 Target 2 | 24.13 (+200.49%) | Price Action: Chart |
2025 Target 1 | 23.89 (+197.50%) | Fibonacci Extension Level 64.90% |
Current Price | 8.03 | M. K. Proteins's share price as of 20 Dec 2024 |
Stop Loss 1 | 4.17 (-48.07%) | Price Action: Chart |
Stop Loss 2 | 4.13 (-48.57%) | Price Action: Chart |
Stop Loss 3 | 4.06 (-49.44%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: M. K. Proteins is currently trading near its 52-week low of ₹7.2, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -71.33% | 3-year: +508.33% | 5-year: +942.86%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
M. K. Proteins Brief Company Overview
M. K. Proteins Limited: A Reputable Player in the Edible Oil Industry Established in 2012 and based in Ambala, India, M. K. Proteins Limited is a leading manufacturer and trader of vegetable refined oil and by-products. With a diverse product range including refined rice bran,...
sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils, the company caters to various industry needs. Beyond edible oils, M. K. Proteins also provides by-products such as rice bran fatty acid oils, rice bran waxes, gums, and spent earth. This diverse product range reflects the company's commitment to providing comprehensive solutions to its customers.M. K. Proteins Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 292.4 Crore | Market valuation of M. K. Proteins's shares. |
Revenue (TTM) | 227.15 Crore | Total revenue generated by M. K. Proteins over the past twelve months. |
Net Income (TTM) | +112,027,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | +6.39% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | +4.93% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) |
-24.80% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) |
-0.40% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio |
32.88 | Company's total debt divided by total shareholder equity. |
Total Debt | 20.08 Crore | Sum of M. K. Proteins's current & long-term financial obligations. |
Total Cash | 9.23 Lakh | Total amount of liquid funds available to M. K. Proteins. |
Beta | -0.31 | Beta is less than 1 indicating that the M. K. Proteins's price is less volatile than the market. |
Is M. K. Proteins A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.